Recommend a female fertility topic for oration in Indian national fee conference who does routine icsi, FET cycle in 2 tier city
female fertility ICSI FET cycle outcomes optimization current trends
Assessment and Management of Polycystic Ovary Syndrome
Page 176
frozen embryo transfer endometrial preparation protocols ERA receptivity
Recurrent Implantation Failure
Page 9
This topic is perfectly positioned for a national audience. The freeze-all strategy has swept Indian IVF, but RCT data (including the FRESH trial and others) shows no universal benefit for normoresponders. A tier-2 practitioner questioning dogma from her own practice data makes a compelling, evidence-based oration. Covers endometrial receptivity, OHSS risk, cost burden on patients, and progesterone rise triggers.
| # | Topic | Why It Works |
|---|---|---|
| 1 | Progesterone on the day of trigger in GnRH antagonist ICSI cycles — should it change your decision? | Hot debate; directly changes daily clinical decisions; data from Venetis, ESHR 2024 meta-analyses |
| 2 | Endometrial receptivity testing (ERA) in FET cycles — evidence vs. commerce in Indian practice | Hugely relevant; ERA is heavily marketed in India; IGENOMIX data vs. RCT data; audience will engage |
| 3 | Optimal endometrial preparation for FET — Natural cycle vs. HRT vs. modified natural: Which protocol deserves your default? | Core FET topic, evolving evidence, suits tier-2 (no advanced lab tools needed) |
| 4 | PCOS and IVF — GnRH agonist trigger + freeze-all: Has it become our ethical obligation? | High PCOS prevalence in India; OHSS prevention is tier-2 relevant; strong ethical + evidence angle |
| 5 | Recurrent implantation failure (RIF) — Stripping away the myths: What actually works? | Always a conference favourite; covers endometrial scratching, PRP, hysteroscopy, thrombophilia workup — separating signal from noise |
| 6 | Poor ovarian response — Is POSEIDON changing how we counsel and treat in routine Indian practice? | POSEIDON classification is now mainstream; links to ICSI outcomes, donor egg counselling, personalised stimulation |
| 7 | Luteal phase support in FET cycles — Vaginal vs. oral vs. subcutaneous progesterone: Does the route matter? | Practical, evidence-based, cost-sensitive (tier-2 angle), recent RCT data available |
| 8 | The forgotten uterus in IVF — When to do hysteroscopy before ICSI/FET and when not to | Hysteroscopy overuse is a real issue in India; gives a balanced, guideline-driven oration |